BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34056977)

  • 1. GE11 Modified PLGA/TPGS Nanoparticles Targeting Delivery of Salinomycin to Breast Cancer Cells.
    Li K; Pang L; Pan X; Fan S; Wang X; Wang Q; Dai P; Gao W; Gao J
    Technol Cancer Res Treat; 2021; 20():15330338211004954. PubMed ID: 34056977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
    Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
    Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGFR-targeting PLGA-PEG nanoparticles as a curcumin delivery system for breast cancer therapy.
    Jin H; Pi J; Zhao Y; Jiang J; Li T; Zeng X; Yang P; Evans CE; Cai J
    Nanoscale; 2017 Nov; 9(42):16365-16374. PubMed ID: 29052674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting.
    Aydın RS
    J Biomed Mater Res A; 2013 May; 101(5):1405-15. PubMed ID: 23086911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma.
    Du L; Xu Y; Han B; Wang Y; Zeng Q; Shao M; Yu Z
    J Cancer Res Ther; 2023 Dec; 19(6):1544-1551. PubMed ID: 38156920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
    Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
    Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy.
    Tao W; Zeng X; Liu T; Wang Z; Xiong Q; Ouyang C; Huang L; Mei L
    Acta Biomater; 2013 Nov; 9(11):8910-20. PubMed ID: 23816645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
    Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
    Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation.
    Chiesa E; Pisani S; Colzani B; Dorati R; Conti B; Modena T; Braekmans K; Genta I
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30082640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
    Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
    Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA-TPGS for the treatment of liver cancer.
    Wu B; Liang Y; Tan Y; Xie C; Shen J; Zhang M; Liu X; Yang L; Zhang F; Liu L; Cai S; Huai D; Zheng D; Zhang R; Zhang C; Chen K; Tang X; Sui X
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():792-800. PubMed ID: 26652434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
    Mao J; Meng X; Zhao C; Yang Y; Liu G
    Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted salinomycin delivery with EGFR and CD133 aptamers based dual-ligand lipid-polymer nanoparticles to both osteosarcoma cells and cancer stem cells.
    Chen F; Zeng Y; Qi X; Chen Y; Ge Z; Jiang Z; Zhang X; Dong Y; Chen H; Yu Z
    Nanomedicine; 2018 Oct; 14(7):2115-2127. PubMed ID: 29898423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment.
    Chen XP; Li Y; Zhang Y; Li GW
    Drug Des Devel Ther; 2019; 13():3569-3578. PubMed ID: 31802845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer.
    Zeng X; Tao W; Mei L; Huang L; Tan C; Feng SS
    Biomaterials; 2013 Aug; 34(25):6058-67. PubMed ID: 23694904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salinomycin nanoparticles interfere with tumor cell growth and the tumor microenvironment in an orthotopic model of pancreatic cancer.
    Daman Z; Faghihi H; Montazeri H
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1434-1442. PubMed ID: 29619850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Nanocurcumin Therapy Using Annexin A2 Anitbody Improves Tumor Accumulation and Therapeutic Efficacy Against Highly Metastatic Breast Cancer.
    Mukerjee A; Ranjan AP; Vishwanatha JK
    J Biomed Nanotechnol; 2016 Jul; 12(7):1374-92. PubMed ID: 29336533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer-lipid hybrid anti-HER2 nanoparticles for targeted salinomycin delivery to HER2-positive breast cancer stem cells and cancer cells.
    Li J; Xu W; Yuan X; Chen H; Song H; Wang B; Han J
    Int J Nanomedicine; 2017; 12():6909-6921. PubMed ID: 29075110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
    Wang Q; Yen YT; Xie C; Liu F; Liu Q; Wei J; Yu L; Wang L; Meng F; Li R; Liu B
    Drug Deliv; 2021 Dec; 28(1):510-519. PubMed ID: 33657950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.